The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

CVS Health today announced Prem Shah will be group president, and will continue to report to David Joyner, president and CEO. In addition, the company announced the appointment of Steve Nelson as ...

After a preliminary announcement a few weeks ago that included a CEO change, CVS Health CVS released its full third-quarter ...

CVS Health Chief Executive Officer Karen Lynch has stepped down and will be replaced by David Joyner, who runs the company's pharmacy benefit firm, Caremark.

Q3 2024 Earnings Conference Call November 6, 2024 8:00 AM ETCompany ParticipantsDavid Joyner - President, Chief ...

The earnings call also featured a first look at David Joyner in his new CEO role after previously leading the Caremark pharmacy ... healthcare services and specialty pharmacy offset the loss ...

This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their ...

He led the pharmacy services business, which serves about 90 million members through Caremark, CVS Specialty and other areas. He also joined the board of directors, and Board Chair Roger Farah was ...

He led the pharmacy services business, which provides solutions to employers, health plans and government entities and serves approximately 90 million members through Caremark, CVS Specialty ...

CVS Caremark said it used ... has combined health insurers with pharmacy benefit managers — including their operating their own retail, mail-order and specialty pharmacies — has created ...